Expression and purification of full-length human Bax α

被引:39
作者
Montessuit, S [1 ]
Mazzei, G [1 ]
Magnenat, E [1 ]
Antonsson, B [1 ]
机构
[1] Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
关键词
D O I
10.1006/prep.1998.1010
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Bax is a proapoptotic ion channel forming protein of the Bcl-2 family. In cells the protein is found in the cytosol and in the mitochondria membrane where it presumably is involved during apoptosis in disruption of the mitochondrial membrane potential and release of cytochrome c. The protein has a hydrophobic domain at the C-terminus, which renders it a limited solubility. Thus, all studies on recombinant Bax has so far been performed on C-terminal truncated protein. We have expressed and purified the full-length human Bax alpha. The protein was expressed with a His tag at the N-terminus and purified by affinity chromatography on Ni-NTA-agarose followed by ion-exchange chromatography on Q-Sepharose, The protein was more than 98% pure on SDS-PAGE and in the presence of 1% (w/v) octyl glucoside it could be concentrated up to 0.5 mg/ml. Full-length Bax was 25-fold more efficient, compared to C-terminal truncated Bax, in forming ion channels and trigger carboxyfluorescein release from liposomes. (C) 1999 Academic Press.
引用
收藏
页码:202 / 206
页数:5
相关论文
共 25 条
[1]   Inhibition of Bax channel-forming activity by Bcl-2 [J].
Antonsson, B ;
Conti, F ;
Ciavatta, A ;
Montessuit, S ;
Lewis, S ;
Martinou, I ;
Bernasconi, L ;
Bernard, A ;
Mermod, JJ ;
Mazzei, G ;
Maundrell, K ;
Gambale, F ;
Sadoul, R ;
Martinou, JC .
SCIENCE, 1997, 277 (5324) :370-372
[2]  
BERNARD AR, 1995, CURRENT PROTOCOLS PR
[3]   DISSECTION OF FUNCTIONAL DOMAINS IN BCL-2-ALPHA BY SITE-DIRECTED MUTAGENESIS [J].
BORNER, C ;
OLIVER, R ;
MARTINOU, I ;
MATTMANN, C ;
TSCHOPP, J ;
MARTINOU, JC .
BIOCHEMISTRY AND CELL BIOLOGY, 1994, 72 (11-12) :463-469
[4]   THE PROTEIN BCL-2-ALPHA DOES NOT REQUIRE MEMBRANE ATTACHMENT, BUT 2 CONSERVED DOMAINS TO SUPPRESS APOPTOSIS [J].
BORNER, C ;
MARTINOU, I ;
MATTMANN, C ;
IRMLER, M ;
SCHAERER, E ;
MARTINOU, JC ;
TSCHOPP, J .
JOURNAL OF CELL BIOLOGY, 1994, 126 (04) :1059-1068
[5]   HIGH EXPRESSION OF LATENT MEMBRANE-PROTEIN-1 OF EPSTEIN-BARR-VIRUS AND BCL-2 ONCOPROTEIN IN ACQUIRED IMMUNODEFICIENCY SYNDROME-RELATED PRIMARY BRAIN LYMPHOMAS [J].
CAMILLERIBROET, S ;
DAVI, F ;
FEUILLARD, J ;
BOURGEOIS, C ;
SEILHEAN, D ;
HAUW, JJ ;
RAPHAEL, M .
BLOOD, 1995, 86 (02) :432-435
[6]   New members of the Bcl-2 family and their protein partners [J].
Farrow, SN ;
Brown, R .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (01) :45-49
[7]   Cytosol-to-membrane redistribution of Bax and Bcl-X-L during apoptosis [J].
Hsu, YT ;
Wolter, KG ;
Youle, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3668-3672
[8]   The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4 [J].
Huang, DCS ;
Adams, JM ;
Cory, S .
EMBO JOURNAL, 1998, 17 (04) :1029-1039
[9]   APOPTOSIS - BASIC BIOLOGICAL PHENOMENON WITH WIDE-RANGING IMPLICATIONS IN TISSUE KINETICS [J].
KERR, JFR ;
WYLLIE, AH ;
CURRIE, AR .
BRITISH JOURNAL OF CANCER, 1972, 26 (04) :239-+
[10]   The proto-oncogene Bcl-2 and its role in regulating apoptosis [J].
Kroemer, G .
NATURE MEDICINE, 1997, 3 (06) :614-620